119 related articles for article (PubMed ID: 9257781)
1. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
Fricker M; Helbling A; Schwartz L; Müller U
J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
[TBL] [Abstract][Full Text] [Related]
2. Specific immunotherapy using Hymenoptera venom: systematic review.
Watanabe AS; Fonseca LA; Galvão CE; Kalil J; Castro FF
Sao Paulo Med J; 2010 Jan; 128(1):30-7. PubMed ID: 20512278
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Cytokine Response Induced by Specific Allergen Immunotherapy in Patients with Vespa velutina Anaphylaxis.
López-Freire S; Armisén M; Cruz MJ; Vidal C
Int Arch Allergy Immunol; 2024; 185(5):456-459. PubMed ID: 38412847
[TBL] [Abstract][Full Text] [Related]
4. Skin Tests versus Serology: Specific IgE May Suffice for Diagnosis of Vespid Venom Allergy and Follow-Up of Allergen Immunotherapy.
Hollstein MM; Matzke SS; Lorbeer L; Traidl S; Forkel S; Möbs C; Fuchs T; Lex C; Buhl T
Int Arch Allergy Immunol; 2023; 184(8):744-753. PubMed ID: 37044077
[TBL] [Abstract][Full Text] [Related]
5. A Quality-of-life Study in Patients with Anaphylaxis to Hymenoptera Venom in Iran.
Bemaniyan MH; Heidari M; Tavakol M; Nabavi M; Ramezani Kashal F; Gholami M; Bemaniyan B
Iran J Allergy Asthma Immunol; 2024 Feb; 23(1):59-68. PubMed ID: 38485910
[TBL] [Abstract][Full Text] [Related]
6. HαT is associated with increased risk for severe Hymenoptera venom-triggered anaphylaxis.
Šelb J; Rijavec M; Kopač P; Lyons JJ; Korošec P
J Allergy Clin Immunol; 2023 Mar; 151(3):804-805. PubMed ID: 36529562
[No Abstract] [Full Text] [Related]
7. Current Advances in Immunological Studies on the Vespidae Venom Antigen 5: Therapeutic and Prophylaxis to Hypersensitivity Responses.
Bazon ML; Silveira LH; Simioni PU; Brochetto-Braga MR
Toxins (Basel); 2018 Jul; 10(8):. PubMed ID: 30042313
[TBL] [Abstract][Full Text] [Related]
8. The role of molecular diagnosis in anaphylactic patients with dual or triple-sensitization to Hymenoptera venoms.
Bemanian MH; Shokouhi Shoormasti R; Arshi S; Jafari M; Shokri S; Fallahpour M; Nabavi M; Zaremehrjardi F
Allergy Asthma Clin Immunol; 2024 Mar; 20(1):22. PubMed ID: 38521942
[TBL] [Abstract][Full Text] [Related]
9. Remission of a case of multiple Hymenoptera stings-associated chronic urticaria during venom immunotherapy.
Dubini M; Pravettoni V; Rivolta F; Segatto G; Asero R; Montano N
Clin Case Rep; 2021 May; 9(5):e04188. PubMed ID: 34026184
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with venom immunotherapy side-effects, re-sting reactions, and adherence in real-life.
Parke L; Kjaer HF; Halken S; Bindslev-Jensen C; Mortz CG
Clin Exp Allergy; 2024 May; 54(5):359-361. PubMed ID: 38456221
[No Abstract] [Full Text] [Related]
11. Hymenoptera Venom Immunotherapy Meets Factitious Disorder.
Stratopoulos E; Leonardou A; Pitsios C
Cureus; 2024 Mar; 16(3):e55769. PubMed ID: 38586777
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a 7-week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom.
Kasternow B; Kim DS; Yong PFK
Allergy; 2024 May; ():. PubMed ID: 38699933
[No Abstract] [Full Text] [Related]
13. Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel.
Velloso EDRP; Padulla GA; de Cerqueira AMM; de Sousa AM; Sandes AF; Traina F; Seguro FS; Nogueira FL; Pereira GF; Boechat JL; Pagnano KBB; Marchi LL; Ensina LF; Giavina-Bianchi M; Aun MV; Agondi RC; Santos FPS; Giavina-Bianchi P
Hematol Transfus Cell Ther; 2022; 44(4):582-594. PubMed ID: 35688791
[TBL] [Abstract][Full Text] [Related]
14. Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia.
O'Connell MP; Lyons JJ
Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):431-437. PubMed ID: 32769710
[TBL] [Abstract][Full Text] [Related]
15. Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.
González-de-Olano D; Matito A; Orfao A; Escribano L
F1000Res; 2016; 5():2666. PubMed ID: 27909577
[TBL] [Abstract][Full Text] [Related]
16. Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.
Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
Curr Allergy Asthma Rep; 2015 Aug; 15(8):49. PubMed ID: 26149588
[TBL] [Abstract][Full Text] [Related]
17. Anaphylaxis as a clinical manifestation of clonal mast cell disorders.
Matito A; Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; Orfao A; Escribano L
Curr Allergy Asthma Rep; 2014 Aug; 14(8):450. PubMed ID: 24947681
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders.
Valent P
Clin Exp Allergy; 2014 Jul; 44(7):914-20. PubMed ID: 24702655
[TBL] [Abstract][Full Text] [Related]
19. Management of insect sting hypersensitivity: an update.
Pesek RD; Lockey RF
Allergy Asthma Immunol Res; 2013 May; 5(3):129-37. PubMed ID: 23638310
[TBL] [Abstract][Full Text] [Related]
20. Twelve-hour ultrarush immunotherapy in a patient with mastocytosis and hymenoptera sting anaphylaxis.
Jäger D; Barth J
World Allergy Organ J; 2009 Mar; 2(3):37-9. PubMed ID: 23282952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
